Sergei Tjulandin
机构: N.N.Blokhin Russian Cancer Research Center
每年引用次数
引用次数
引用: 34,600
H-指数: 64
I10-指数 : 143
出版物: 501
Lapatinib (L) with weekly paclitaxel (P) as first-line therapy for patients (pts) with HER2+ metastatic breast cancer (MBC).
A Jagiello-Gruszfeld , S Tjulandin Sergei , N Dobrovolskaya , A Manikhas
Cancer Research 69 3145
4
2009
A Three‐Arm Randomized Phase II Study of Oral Vinorelbine Plus Capecitabine Versus Oral Vinorelbine and Capecitabine in Sequence Versus Docetaxel Plus Capecitabine in Patients with Metastatic Breast Cancer Previously Treated with Anthracyclines
Mario Campone , Natalya Dobrovolskaya , Serjei Tjulandin , Shin‐Chen Chen
Breast Journal 19 ( 3) 240 -249
13
2013
Distribution of EGFR Mutations in 10,607 Russian Patients with Lung Cancer.
Evgeny N. Imyanitov , Irina A. Demidova , Marat G. Gordiev , Maxim L. Filipenko
Molecular Diagnosis & Therapy 20 ( 4) 401 -406
53
2016
Nuclear Protein of the Testis Midline Carcinoma Masquerading as a Primary Mediastinal Seminoma.
Maria S. Sayapina , Nikita A. Savelov , Apollon I. Karseladze , Anatoly A. Bulanov
Rare Tumors 8 ( 2) 6241 -6241
2
2016
Effect of starting dose of regorafenib on overall survival of patients with metastatic colorectal cancer: a systematic review and meta-analysis
Mikhail Yu Fedyanin , Elizaveta M Polyanskaya , Alexey A Tryakin , Ilia A Pokataev
Journal of Modern Oncology 21 ( 3) 10 -15
2019
First and Subsequent Cycle Use of Pegfilgrastim Prevents Febrile Neutropenia in Patients With Breast Cancer: A Multicenter, Double-Blind, Placebo-Controlled Phase III Study
Charles L Vogel , Marek Z Wojtukiewicz , Robert R Carroll , Sergei A Tjulandin
Journal of Clinical Oncology 23 ( 6) 1178 -1184
389
2005
Changes from baseline health related quality of life (HRQOL) analysis: No compromise by adding docetaxel to a cisplatin-based regimen in advanced gastric cancer patients, including those experiencing febrile neutropenia (FN) or neutropenic infection (NI)
Jaffer A Ajani , Vladimir Moiseyenko , Sergei A Tjulandin , Alejandro Majlis
Annals of Oncology 17 314 -315
1
2006
Original Reports-GASTROINTESTINAL CANCER-Phase II Multi-Institutional Randomized Trial of Docetaxel Plus Cisplatin With or Without Fluorouracil in Patients With Untreated, Advanced Gastric, or
Jaffer A Ajani , Miguel B Fodor , Sergei A Tjulandin , Vladimir M Moiseyenko
Journal of Clinical Oncology 23 ( 24) 5660 -5667
2005
Original Reports-BREAST CANCER-First and Subsequent Cycle Use of Pegfilgrastim Prevents Febrile Neutropenia in Patients With Breast Cancer: A Multicenter, Double-Blind, Placebo-Controlled Phase
Charles L Vogel , Marek Z Wojtukiewicz , Robert R Carroll , Sergei A Tjulandin
Journal of Clinical Oncology 23 ( 6) 1178 -1184
2005
P2. 12 Estrogen receptor beta expression in non-small cell lung cancer and lung metastases of different primary tumors
Tatiana A Bogush , Alexandra S Shaturova , Evgenyi A Dudko , Elena A Shestakova
Safety and efficacy of ribociclib in combination with letrozole in an extended population of patients with HR+/HER2-advanced breast cancer: analysis of data from a subgroup of patients from Russia in the phase lllb CompLEEment-1 study
Liudmila G Zhukova , Larisa V Bolotina , Victoria V Dvornichenko , Natalia V Fadeeva
Journal of Modern Oncology 26 ( 1) 56 -64
2024
Second-Line Chemotherapy for Advanced Gastric Cancer.
Dheepak Kanagavel , Sergei A Tjulandin
European Journal of Clinical & Medical Oncology 4 ( 2)
2012
Outcome of Patients (Pts) with Extragonadal Mediastinal Seminomas: a Single Institute Expierence
E Polotskiy Boris , Bakhrom B Akhmedov , Alexey A Tryakin , Sergei A Tjulandin
2006
BREAST CANCER-Breast Cancer Abstracts-Randomized, Open-Label, Phase III, Multicenter Trial Comparing AT (Doxorubicin, Paclitaxel) Versus FAC (5-Fluorouracil, Doxorubicin, Cyclophosphamide) as
Sergei A Tjulandin
Seminars in Oncology-Supplements 26 ( 18) 10 -10
1999
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D Von Hoff , Thomas Ervin , Francis P Arena , E Gabriela Chiorean
The New England Journal of Medicine 369 ( 18) 1691 -1703
5,764
2013
Somatic mutations of KIT in familial testicular germ cell tumours.
E A Rapley , S Hockley , W Warren , L Johnson
British Journal of Cancer 90 ( 12) 2397 -2401
84
2004
Clinical Predictors of Second-Line Chemotherapy Benefit in Patients with Pancreatic Cancer
Ilya Pokataev , Nikolay Kudashkin , Mikhail Fedyanin , Sergey Gordeev
Journal of the Pancreas 18 ( 3)
1
2017
000416 TREATMENT OF CERVICAL CANCER T1B2–2BNO-1MO: RESULTS OF 5-YEAR FOLLOW-UP
V. M. Nechushkina , K. Y. Morkhov , V. V. Kuznetsov , L. S. Usmanova
International Journal of Gynecologic Cancer 15 166 -166
2005
Targeted therapy in the treatment of solid tumors: practice contradicts theory.
N. V. Zhukov , S. A. Tjulandin
Biochemistry 73 ( 5) 605 -618
40
2008
Quantitative immunofluorescence estimation of Pgp expression in human solid tumors by flow cytometry
T. A. Bogush , M. V. Tikhomirov , E. A. Dudko , M. N. Sinitsyna
Moscow University Chemistry Bulletin 67 ( 3) 142 -148
4
2012